BCKDK antibody
Ref. 3D-10R-3424
| 100µl | 1.084,00 € |
Información del producto
The BCKDK antibody is a cytotoxic monoclonal antibody that acts as an inhibitor of tyrosine binding proteins. It has been extensively studied in the field of Life Sciences and has shown promising results in various applications. This antibody specifically targets CXCL13, a matrix metalloproteinase that plays a crucial role in cell migration and tissue remodeling.
One of the key features of the BCKDK antibody is its high specificity and affinity towards its target. It binds to CXCL13 with exceptional precision, effectively blocking its activity and preventing unwanted cell migration. This makes it an ideal tool for researchers studying cellular processes and pathways related to inflammation, immune response, and cancer metastasis.
In addition to its inhibitory properties, the BCKDK antibody also exhibits therapeutic potential. It can be conjugated with other compounds or used in combination with existing treatments to enhance their efficacy. Studies have shown that this antibody has significant anti-tumor effects, making it a promising candidate for cancer therapy.
Furthermore, the
Propiedades químicas
Consulta técnica sobre: 3D-10R-3424 BCKDK antibody
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
